Oncotelic Therapeutics, Inc. (OTLC) Total liabilities 2013–2024
Oncotelic Therapeutics, Inc. (OTLC) total liabilities at each fiscal year-end, per SEC filings.
$18.4MFY2024 · since FY2013: $901,000 → $18.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $18.4M | — |
| FY2021 | $11.9M | — |
| FY2014 | $1.3M | +38.8% |
| FY2013 | $901,000 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice